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IntroductIon
Gender validation is thought to be an integral part of data 
verification for demographic information in large-scale 
population studies. High quality data and highly consistent 
biospecimens are major requirements for biospecimen 
repository to ensure the highest validity in basic and 
translational research. Gender validation is also seen as 
a critical part of the quality control process for genomic 
application particularly in mutation studies [1]. By 
validating the gender data, errors that could adversely affect 
the sequencing results can be minimised or eliminated and 
the accountability of the biospecimens can be assured.
Driven by the scale of samples in biospecimen 
repositories, gender validation requires a highly sensitive, 
rapid and reliable detection method. To date, none has 
reported the application of genetic markers in gender 
validation as part of quality assurance of biospecimen 
repositories and quality control prior to full genetic 
analysis.
In humans, the sex determining region of the Y 
chromosome (SRY) has been reported to be responsible 
for the development of the male characters [2]. The SRY 
loci on the short arm of Y chromosome has been shown to 
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ABStrAct
Gender validation is indispensable in data verification for demographic information particularly in large-scale 
population studies and also as part of the quality assurance of biospecimen repositories. Gender validation is 
also critical as part of quality control processes before specimens are subjected to sequencing analysis to identify 
germline and somatic mutations. the SrY gene is considered a useful signature gene marker that differentiates 
male from female. the aim of the study was to validate the SrY gene marker for use in gender determination in 
large cohort studies. SrY gene-specific sequences were amplified by Pcr, electrophoresed on agarose gels and the 
254 bp band was visualized for male samples. A series of dnA template concentrations were tested for sensitivity 
determination. the reaction was validated on 48 gender-blinded samples obtained from the uMBI BioBank to 
determine the specificity. AtL1 gene-specific sequence on X chromosome was used as the internal control. this 
Pcr method has demonstrated 100% gender specificity. the sensitivity of the reaction was demonstrated with 
as low as 0.1 ng male dnA. the findings had suggested that SRY analysis by Multiplex Pcr is a highly sensitive 
and specific method for gender determination and can be extremely useful for large-scale samples.
be the testis-determining factor (TDF) that initiates male 
sex determination [3]. Hence, the detection of SRY gene is 
thought to be able to distinguish a male DNA sample from 
a female. We used a multiplex PCR method to validate the 
SRY gene marker for use in gender determination.
Materials and Methods
STUDY SAMPLES
A total of 48 samples were obtained from the UMBI 
Biobank for the gender validation study. The gender 
information for each sample was only revealed after the 
analysis has been completed.
DNA ISOLATION AND QUANTIFICATION
Total genomic DNA from the blood samples were 
extracted by using an improved salt-extraction method 
[4]. The vacuum-dried DNA samples were then dissolved 
in Tris–EDTA (TE) buffer and the DNA concentrations 
were determined by using a Nanodrop® ND-1000 
Spectrophotometer (Thermo Scientific, USA) at A260/
A280.
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MULTIPLEX POLYMERASE CHAIN REACTION (PCR)
PCR reactions were prepared using QIAGEN® 
HotStarTaq® Master Mix (Qiagen, Germany) according 
to the manufacturer’s protocol. The PCR mixture consisted 
of 50 ng DNA and 0.1 µM of each set of primers (SRY and 
ATL1). The ATL1 gene was used as an internal control. 
The oligonucleotide primer sequences were as shown in 
Table 1. To monitor for contamination, negative (without 
DNA) and positive (male and female DNA) controls were 
included into the PCR reactions.
     Table 1: Oligonucleotide primers for amplification of the SRY and ATL1 gene specific sequences
 Gene     Forward Primer (5’)     Reverse Primer (3’) Base pair
 SRY CATGAACGCATTCATCGTGTGGTC CTGCGGGAAGCAAACTGCAATTCTT 254
 ATL1 CCCTGATGAAGAACTTGTATCTC GAAATTACACACATAGGTGGCACT 301
PCR reactions were performed in a Veriti® 96 Well 
Thermal Cycler (Applied Biosystems, USA). The DNA 
template was initially denatured for 15 min at 95°C and 
followed by 35 PCR cycles as follows: DNA denaturation 
for 1 min at 94°C, annealing for 1 min at 57.1°C and 
elongation for 1 min at 72°C, with a final extension of the 
cycle at 72°C for 10 min.
To determine the sensitivity of the reaction, different 
concentration of DNA templates were used ranging from 
0.01, 0.1, 1.0, 10 and 100 ng. For this sensitivity testing, 
DNA from a male individual was applied in the PCR 
reactions to enable the comparison between 254bp and 
301bp band intensities at the varying amounts of DNA.
AGAROSE GEL ELECTROPHORESIS
Electrophoresis of the PCR products was carried out using 
approximately 2.5 ng of template DNA (diluted DNA from 
PCR product) on 2% (w/v) agarose gels in 1 X TAE buffer 
for 90 minutes at 50 V/cm. Subsequently, the gels were 
stained in GelStar® Nucleic Acid Gel Stain and visualized 
under ultraviolet light.
ASSESSMENT OF SENSITIVITY AND SPECIFICITY
Sensitivity of this method was assessed by the proportion 
of actual positives which were correctly identified (correct 
gender) whereas the specificity was determined by the 
proportion of negatives which were correctly identified. 
The calculation of sensitivity and specificity is described 
as follows:
Sensitivity (%) 
= [number of true positives / (number of true positives + 
number of false negatives)] × 100
Specificity (%) 
= [number of true negatives / (number of true negatives + 
number of false positives)] × 100
results
We successfully amplified and detected the SRY and ATL1 
amplicons with bands at 254bp and 301bp respectively. 
Male samples were distinguished from female samples by 
the presence of SRY gene-specific bands at 254bp. PCR 
products observed at both 254bp and 301bp indicated that 
the DNA originated from a male sample whereas samples 
from female individual showed only a single PCR product 
at 301bp (Figure 1). The presence of ATL1 gene-specific 
bands at 301bp has been consistently observed in all 
samples, thus demonstrates the reliability of this gene as 
an internal control. A representative gel image from the 
validation study on the gender-blinded samples (19 out of 
48 samples) is shown in Figure 2.
The sensitivity and specificity of this technique 
established using the 48 unknown samples were both 100% 
(Table 2), with no false-positive or false-negative result 
observed. Our study had correctly identified the gender 
for all of the samples with 100% accuracy.
High sensitivity of this PCR reaction was achieved as 
demonstrated by the minimum amount of 0.1 ng of DNA 
template required for a successful SRY gene detection 
(Figure 3).
discussion
Gender determination of human DNA samples in a 
rapid and accurate manner is essential in several settings 
including clinical practice in determining sex chromosome-
linked genetic disorders, prenatal sex determination, 
forensic investigation and basic research. The gender 
determination is also used as part of a quality control in 
large biorepositories as well as when undertaking large 
studies using archived biospecimens. Over the years, 
several techniques have been employed to determine 
the sex of the donor of a human DNA sample including 
karyotyping for chromosomal disorders [5, 6], short tandem 
repeat (STR) in routine forensic DNA analysis [7, 8] and 
multiplex-polymerase chain reaction (PCR) in prenatal 
[7] and ancient human skeletons [9] gender determination. 
Given the advancement in technology today, the screening 
of gender on a large number of samples, particularly in 
cohort studies and biorepositories, using a high-throughput, 
rapid and economic manner is made possible by the 
development of DNA-based techniques.
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Figure 1: PCR amplification on both male and female samples. Lane 1 & 4: 100 bp marker; Lane 2: Male sample with only
SRY primer; Lane 3: Female sample with only ATL1 primer; Lane 5: Male sample with SRY and ATL1 primers; Lane 6:
Female sample with SRY and ATL1 primers; Lane 7: Negative control (water). Female DNA sample showed a PCR
product at 301bp whereas male DNA sample showed two PCR fragments at 254 and 301bp.
Figure 2: A representative gel image from the validation study on gender-blinded samples (19 out of 48 samples).
PCR amplification was done by using SRY and ATL1 primers.
Figure 3: PCR amplification of a series of DNA template concentrations for sensitivity determination. Lane 1: 100 base-pair 
marker; Lane 2: 100 ng DNA template (10 ng/2 µL PCR product); Lane 3: 10 ng DNA template (1.0 ng/2 µL PCR product);
Lane 4: 1.0  ng DNA template (0.1 ng/2 µL PCR product); Lane 5: 0.1 ng DNA template (10 x 10-3 ng/2 µL PCR product);
Lane 6: 0.01 ng DNA template (10 x 10-4 ng/2 µL PCR product); Lane 7: Negative control (water). SRY gene specific
sequence was successfully detected with DNA sample as low as 0.1ng.
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For this purpose, we have employed a simple 
multiplex PCR amplification of the SRY gene and the 
X-chromosome specific ATL1 gene and have successfully 
determined the sex of all unknown samples with 100% 
accuracy. The ATL1-specific fragment has been reported 
to be a reliable internal control for the non-invasive fetal 
sex determination in pregnant women [10]. This gene is 
located on the long arm of the X chromosome at Xq27.3 
and directed the amplification of a 301 base pair fragment 
in all individuals [11].
We also demonstrated a higher sensitivity for this PCR 
reaction using a minimum DNA quantity of 0.1ng. Kastelic 
et al. 2009 reported the requirement of 125pg of DNA for 
SRY marker detection in male gender identification for 
their forensic casework [12].
In conclusion, our results have shown that we have 
successfully developed a very reliable, sensitive and 
specific method to differentiate between the male and 
female samples. Furthermore, the method requires only 
one multiplexed polymerase chain reaction in the workflow 
with a small amount of DNA and a minimum cost of 
RM10.42 per sample.
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